包含TRPA1拮抗劑的納米顆粒製劑

• 收藏
• 分享

专利权人:

Glenmark Pharmaceuticals S.A.

发明人:

DHUPPAD Ulhas,CHAUDHARI Sunil,RAJURKAR Suresh,JAIN Nilesh

申请号：

HK16109317.9

公开号：

HK1221161A

申请日:

2016.08.04

申请国别(地区):

HK

年份:

2017

代理人:

摘要：

The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor (“TRPA1”) antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer； a process for preparing such formulation； and its use in treating a respiratory disorder or pain in a subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/